Comparative Efficacy and Selectivity of Pharmacological Inhibitors of DYRK and CLK Protein Kinases
Author:
Affiliation:
1. Perha Pharmaceuticals, Perharidy Peninsula, 29680 Roscoff, France
2. Oncodesign, 25-27 avenue du Québec, 91140 Villebon-sur-Yvette, France
3. Enzymlogic, Qube Technology Park, C/Santiago Grisolía, 2, 28760 Madrid, Spain
Funder
Agence Nationale de la Recherche
European Innovation Council
Fonds Unique Interministériel
Horizon 2020 Framework Programme
Fondation Jérôme Lejeune
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c02068
Reference177 articles.
1. CONVERSION OF PHOSPHORYLASE b TO PHOSPHORYLASE a IN MUSCLE EXTRACTS
2. Protein Phosphorylation and Signal Transduction
3. Trends in kinase drug discovery: targets, indications and inhibitor design
4. Kinase drug discovery 20 years after imatinib: progress and future directions
5. Structural features of the protein kinase domain and targeted binding by small-molecule inhibitors
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Design, synthesis, and biological evaluation of β-carboline-cinnamic acid derivatives as DYRK1A inhibitors in the treatment of diabetes;Bioorganic Chemistry;2024-10
2. Targeting the CLK2/SRSF9 splicing axis in prostate cancer leads to decreased ARV7 expression;Molecular Oncology;2024-09-11
3. DYRK1A signalling synchronizes the mitochondrial import pathways for metabolic rewiring;Nature Communications;2024-06-20
4. Curcumin Inhibition of DYRK Kinases;2024-06-10
5. Targeting the DYRK1A kinase prevents cancer progression and metastasis and promotes cancer cells response to G1/S targeting chemotherapy drugs;npj Precision Oncology;2024-06-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3